Shexiang Baoxin Pill attenuates myocardial ischemia/reperfusion injury by activating autophagy via modulating the ceRNA-Map3k8 pathway
Author:
Publisher
Elsevier BV
Subject
Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine
Reference36 articles.
1. Environmental Determinants of Cardiovascular Disease;Bhatnagar;Circ. Res.,2017
2. From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research";Cabrera-Fuentes;Basic Res. Cardiol.,2016
3. Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis;Cheng;Nat. Commun.,2019
4. Combination of ginsenosides Rb2 and Rg3 promotes angiogenic phenotype of human endothelial cells via PI3K/Akt and MAPK/ERK pathways;Choi;Front. Pharmacol.,2021
5. Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation;Cosin-Roger;Nat. Commun.,2017
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota;Drugs;2024-01-24
2. Phlorizin, a novel caloric restriction mimetic, stimulates hypoxia and protects cardiomyocytes through activating autophagy via modulating the Hif-1α/Bnip3 axis in sepsis-induced myocardial dysfunction;International Immunopharmacology;2024-01
3. Mitigation of Myocardial Ischemia/Reperfusion–induced Chronic Heart Failure via Shexiang Baoxin Pill–Mediated Regulation of the S1PR1 Signaling Pathway;Phytomedicine;2024-01
4. The Shexiang Baoxin Pill Protects Myocardial Cells from Multiple Targets of MIRI through the PI3K/Akt/eNOS Signal Pathway;2023-11-14
5. Dexmedetomidine combined with propofol attenuates myocardial ischemia/reperfusion injury by activating the AMPK signaling pathway;Heliyon;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3